glp-1 fatty liver disease MASH Approval: What Patients Should Know New Data of Semaglutide revels
Description
Concerns have also been raised about possible effects on the pancreas and thyroid
Oral semaglutide (Rybelsus) represents the first oral GLP-1 formulation but is FDA-approved only for type 2 diabetes, not weight management
Unlike unregulated patches, prescription GLP-1 medications go through rigorous FDA review to prove theyre safe, effective, and consistently dosed
Holst, et al (2011)
If you need to lose 15-20% of your body weight, semaglutide may be entirely sufficient
